Membranous glomerulonephropathy in a patient with bullous pemphigoid
M Ikeda, H Honda, N Kobayashi, S Onuma… - CEN Case Reports, 2017 - Springer
… Full size image The cutaneous symptoms with tense blistering suggested an autoimmune
bullous disease, … Thus, we speculated that the IgG4 of anti-BP180 antibody bound to FcRn was …
bullous disease, … Thus, we speculated that the IgG4 of anti-BP180 antibody bound to FcRn was …
Global immunoglobulin supply: steaming towards the iceberg?
J Prevot, S Jolles - Current Opinion in Allergy and Clinical …, 2020 - journals.lww.com
… Maintenance of serum IgG levels is proportionally more dependent on … autoimmune diseases,
which may reduce pressure for Ig on … Novel therapies such as FcRn inhibitors may reduce …
which may reduce pressure for Ig on … Novel therapies such as FcRn inhibitors may reduce …
[HTML][HTML] Ways in which the neonatal Fc-receptor is involved in autoimmunity
J Lamamy, P Boulard, G Brachet, S Tourlet… - … Autoimmunity, 2021 - Elsevier
… This review focuses on the role of FcRn in autoimmunity, … of autoreactive IgG by blocking
FcRn-dependent recycling. … represented category is FcRn-specific, full IgG formats. These …
FcRn-dependent recycling. … represented category is FcRn-specific, full IgG formats. These …
[PDF][PDF] This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and …
VS MONOPATHOGENIC, MEOF PEMPHIGUS - cyberleninka.org
… potentially lethal mucocutaneous blistering disease characterized by IgG autoantibodies (…
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases…
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases…
Biologics in autoimmune bullous diseases: Current scenario
… been proposed/explored for managing autoimmune bullous diseases. These hold potential
for … of various biologics in the treatment of autoimmune bullous diseases, followed by a brief …
for … of various biologics in the treatment of autoimmune bullous diseases, followed by a brief …
Intravenous immunoglobulin treatment abrogates transplacental autoantibody transfer in a murine pemphigus model
… (PV) is an autoimmune skin blistering disease caused by anti-… decreased by IVIG treatment
in a dose-dependent manner, … and mouse FcRn share high homology and human IgG can …
in a dose-dependent manner, … and mouse FcRn share high homology and human IgG can …
The use of IVIg in fetal and neonatal alloimmune thrombocytopenia—Principles and mechanisms
H Wabnitz, R Khan, AH Lazarus - Transfusion and Apheresis Science, 2020 - Elsevier
… also be inhibited by IVIg through a Fc-dependent mechanism. … , autoimmune myasthenia
gravis, skin blistering diseases … that IVIg therapy in FNAIT competitively occupies the FcRn sites …
gravis, skin blistering diseases … that IVIg therapy in FNAIT competitively occupies the FcRn sites …
Autoimmune neurological disorders with IgG4 antibodies: a distinct disease spectrum with unique IgG4 functions responding to anti-B cell therapies
MC Dalakas - Neurotherapeutics, 2022 - Springer
… Antibody therapies targeting FcRn, testing those anti-FcRn … IgG subclass, comprising less
than 5% of the total IgG with … phagocytosis or antibody-dependent cellular cytotoxicity; because …
than 5% of the total IgG with … phagocytosis or antibody-dependent cellular cytotoxicity; because …
[HTML][HTML] Autoantibodies
… -dependent antigen also led to lower antigen-specific IgG titers… neonatal Fc receptor (FcRn)
(43). By administering excess … and healthy skin in experimental pemphigoid disease, several …
(43). By administering excess … and healthy skin in experimental pemphigoid disease, several …
Intravenous immunoglobulins as immunomodulators in autoimmune diseases and reproductive medicine
… Fc-dependent activities (ie, blockade of the neonatal FcRn and … FcRn is a transport receptor
that binds intracellular IgG and … of IVIG treatment (resulting in 2 g and 2.4 g total IVIG doses, …
that binds intracellular IgG and … of IVIG treatment (resulting in 2 g and 2.4 g total IVIG doses, …